BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10166364)

  • 1. Servicing: meeting US and European quality system requirements.
    Donawa ME
    Med Device Technol; 1997 Mar; 8(2):16-8, 20, 22. PubMed ID: 10166364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting US and European supplier control requirements.
    Donawa M
    Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting European and US requirements for design and development documentation, Part II.
    Donawa ME
    Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding surprises when implementing a single quality system.
    Donawa M
    Med Device Technol; 2009; 20(2):28, 30-1. PubMed ID: 19405340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European and US quality system requirements for packaging.
    Donawa ME
    Med Device Technol; 1997 May; 8(4):12-4, 16-7. PubMed ID: 10167684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complying with US and European complaint handling requirements.
    Donawa ME
    Med Device Technol; 1997 Sep; 8(7):12-5. PubMed ID: 10174197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding US labelling requirements.
    Donawa M
    Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complying with US and European change control requirements, Part I.
    Donawa ME
    Med Device Technol; 1997 Oct; 8(8):10-3. PubMed ID: 10174270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing definitions of manufacturer.
    Donawa ME
    Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complying with US and European change control requirements, Part II.
    Donawa ME
    Med Device Technol; 1997 Nov; 8(9):13-6. PubMed ID: 10174625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling the quality of raw materials.
    Donawa ME
    Med Device Technol; 1998; 9(1):12-5. PubMed ID: 10176139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing US and European device testing requirements.
    Donawa M
    Med Device Technol; 2008 Sep; 19(5):32, 34-7. PubMed ID: 18947148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting European and US requirements for design and development documentation, Part I.
    Donawa ME
    Med Device Technol; 1996 Nov; 7(9):12-5. PubMed ID: 10163673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality planning conundrum.
    Donawa ME
    Med Device Technol; 1999; 10(6):14-6. PubMed ID: 10623345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process validation: harmonizing the requirements.
    Donawa ME
    Med Device Technol; 1998 Oct; 9(8):13-6. PubMed ID: 10186986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taking control: the Validation Master Plan.
    Donawa ME
    Med Device Technol; 1995 Dec; 6(10):12-4. PubMed ID: 10158118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical device reporting: another final rule, Part I.
    Donawa M
    Med Device Technol; 2000 Mar; 11(2):40-2. PubMed ID: 10915493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New US agent requirements.
    Donawa M
    Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the new quality management system standards on the CE-marking process.
    Donawa M
    Med Device Technol; 2001; 12(1):34-9. PubMed ID: 11317864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.